GLENMARK PHARMA

14% jump on Friday may still have a further 29% upside, as the stock finds itself in a sweet spot on technical charts, according to multiple market experts. They recommend a ‘buy on dips’ strategy, with a price target of up to Rs 2,800. The stock surged 20% in early trade to hit a lifetime high of Rs 2,284.80, before paring some gains as the session progressed.